May 22, 2017 11:56 PM ET

Pharmaceuticals

Company Overview of Sichuan KELUN PHARMACEUTICAL Co., Ltd.

Company Overview

Sichuan Kelun Pharmaceutical CO., LTD. manufactures and sells pharmaceutical products in the People's Republic of China. Its products include IV fluids, sterile powders for injections, small volume parenteral products, tablets, capsules, granules, oral solutions, dialysis solutions, APIs, pharmaceutical packaging materials, medical devices, antibiotic intermediates, and other products; digestive, cardiovascular, antipsychotic, and respiratory products; and anti-pathogenic microorganisms. The company was founded in 1996 and is based in Chengdu, the People's Republic of China. Sichuan Kelun Pharmaceutical CO., LTD. is a subsidiary of Sichuan Kelun Industry Group CO., LTD.

No.36 West Baihua Road

Qingyang District

Chengdu,  610071

China

Founded in 1996

18,855 Employees

Phone:

86 28 8299 8999

Fax:

86 28 8612 7705

Key Executives for Sichuan KELUN PHARMACEUTICAL Co., Ltd.

Sichuan KELUN PHARMACEUTICAL Co., Ltd. does not have any Key Executives recorded.

Sichuan KELUN PHARMACEUTICAL Co., Ltd. Key Developments

Sichuan KELUN PHARMACEUTICAL Co., Ltd. to Report Q1, 2017 Results on Apr 25, 2017

Sichuan KELUN PHARMACEUTICAL Co., Ltd. announced that they will report Q1, 2017 results on Apr 25, 2017

Sichuan Kelun Pharmaceutical Issues RMB 800 Million 5-Year Corporate Bonds

Sichuan Kelun Pharmaceutical issued RMB 800 million 5-year Corporate Bonds. This is a progressive rate bond whose interest rate rises as the holding period increases. There is no guarantor for the issuance of the bond. The issue date and listing date are March 10 and April 12 respectively, and the maturity date is on March 13, 2022.

Sichuan KELUN PHARMACEUTICAL Co., Ltd., Annual General Meeting, Apr 21, 2017

Sichuan KELUN PHARMACEUTICAL Co., Ltd., Annual General Meeting, Apr 21, 2017, at 15:00 China Standard Time. Agenda: To approve 2016 work report of the board of directors; to approve 2016 work report of the supervisory committee; to approve 2016 annual report and its summary; to approve 2016 financial resolution report; to approve reappointment of 2017 financial audit firm; to approve 2016 profit distribution plan; to approve financing from banks and other financial institutions of the Company and subordinate companies and branches; to approve 2017 continuing connected transactions estimate; to approve the plan for the shareholder return for the next three years from 2017 to 2019; to approve adjustment to the employee equity incentive plan and establishment of relevant principals; to approve share repurchase; and to authorize the board to handle matters in relation to the repurchase.

Recent Private Companies Transactions

Type
Date
Target
Buyback
May 12, 2017
--
Merger/Acquisition
October 28, 2016
KLUS Pharma, Inc.
Merger/Acquisition
August 26, 2016
Zhejiang Guojing Pharmaceutical Co., Ltd.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Sichuan KELUN PHARMACEUTICAL Co., Ltd., please visit www.kelun.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.